Biggest News Aggregation in the World
📰 Ivan Kimuli News

Ivan Kimuli News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ivan Kimuli. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Correction to Lancet Respir Med 2022; 10: 972–84

ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial. Lancet Respir Med 2022; 10: 972–84—In this Article, Thomas L Holland and Ivan Kimuli should have been included in the ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group. This correction has been made to the online version as of Nov 7, 2022.
Ivan Kimuli Thomasl Holland Study Group Respir Med

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science